grantGrants.gov

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Organization National Institutes of HealthPosted 6 Nov 2024Deadline 7 May 2026
HHS-NIH1193.86693.242synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: PAR-25-036 Document Type: synopsis CFDA Numbers: 93.866, 93.242

Read the full description

Sign up freeFree account · No credit card required
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) — National Institutes of Health | Dev Procure